Scapa Healthcare Signs Technology Licensing Agreement with Synedgen for Wound Care Technology
Under the terms of the agreement, Scapa Healthcare has exclusive rights over Synedgen’s glycopolymer technology in the field of dermal wounds and surgical care applications.
Read More